Jannie Borst

10PUBLICATIONS
79CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 01, 2026
Phagocytosis of necroptotic cells optimizes type 1 conventional dendritic cells for induction of a cytotoxic T-cell response.

Mo D Staal, Zhixian Wang, Douwe M T Bosma

|Dec 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.

Muddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam

|May 05, 2025
CD27 costimulation supports metabolic fitness of CD4+ T cells by enhancing de novo nucleotide and protein synthesis.

Thi Tran Ngoc Minh, Lotte J Verleng, Ellen Schrama

|Apr 15, 2025
CD70 recruitment to the immunological synapse is dependent on CD20 in B cells.

Abbey B Arp, Andrea Abel Gutierrez, Martin Ter Beest

|Apr 12, 2023
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Stefan Naulaerts, Angeliki Datsi, Daniel M Borras

Pageof 2